Accelerometry as a measure of walking behavior in multiple sclerosis

Robert W Motl, Lara Pilutti, B. M. Sandroff, D. Dlugonski, Jacob J Sosnoff, J. H. Pula

Research output: Contribution to journalArticle

Abstract

Objective: Accelerometry has been identified as a possible ecologically valid and objective approach for measuring community ambulation in multiple sclerosis (MS). This study provides a validation of accelerometer output based on associations with Expanded Disability Status Scale (EDSS), Patient Determined Disease Steps (PDDS) Scale, and Multiple Sclerosis Walking Scale-12 (MSWS-12) scores, timed 25-foot walk (T25FW) and 6-min walk (6MW) performance, oxygen cost (O 2 cost) of walking, and spatial and temporal parameters of gait. Materials and Methods: 256 persons with MS completed the PDDS and MSWS-12, underwent an examination for the generation of an EDSS score, undertook two T25FW tests and a 6MW while wearing a portable metabolic unit for measuring the O 2 cost of walking, completed two trials of comfortable walking on a GAITRite electronic walkway for measuring spatial and temporal parameters of gait, and then wore an Actigraph accelerometer during the waking hours of a 7-day period. Results: The accelerometer output was significantly correlated with EDSS (ρ = -0.522), PDDS (ρ = -0.551), and MSWS-12 (ρ = -0.617) scores, T25FW (ρ = -0.595) and 6MW (ρ = 0.630) performance, and O 2 cost of walking (ρ = -0.457). Regarding gait parameters, the accelerometer output was significantly correlated with velocity (ρ = 0.420), cadence (ρ = 0.349), step time (ρ = -0.353), step length (ρ = 0.395), double support (ρ = -0.424), and single support (ρ = 0.400). Conclusion: We provide comprehensive evidence from a large sample of persons with MS that further supports accelerometry as a measure of walking behavior.

Original languageEnglish (US)
Pages (from-to)384-390
Number of pages7
JournalActa Neurologica Scandinavica
Volume127
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

Accelerometry
Multiple Sclerosis
Walking
Gait
Costs and Cost Analysis
Oxygen

Keywords

  • Ambulation
  • Mobility
  • Multiple sclerosis
  • Neurology
  • Walking

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Motl, R. W., Pilutti, L., Sandroff, B. M., Dlugonski, D., Sosnoff, J. J., & Pula, J. H. (2013). Accelerometry as a measure of walking behavior in multiple sclerosis. Acta Neurologica Scandinavica, 127(6), 384-390. https://doi.org/10.1111/ane.12036

Accelerometry as a measure of walking behavior in multiple sclerosis. / Motl, Robert W; Pilutti, Lara; Sandroff, B. M.; Dlugonski, D.; Sosnoff, Jacob J; Pula, J. H.

In: Acta Neurologica Scandinavica, Vol. 127, No. 6, 01.06.2013, p. 384-390.

Research output: Contribution to journalArticle

Motl, RW, Pilutti, L, Sandroff, BM, Dlugonski, D, Sosnoff, JJ & Pula, JH 2013, 'Accelerometry as a measure of walking behavior in multiple sclerosis', Acta Neurologica Scandinavica, vol. 127, no. 6, pp. 384-390. https://doi.org/10.1111/ane.12036
Motl, Robert W ; Pilutti, Lara ; Sandroff, B. M. ; Dlugonski, D. ; Sosnoff, Jacob J ; Pula, J. H. / Accelerometry as a measure of walking behavior in multiple sclerosis. In: Acta Neurologica Scandinavica. 2013 ; Vol. 127, No. 6. pp. 384-390.
@article{2c6ee9360e1f44a68cd356c746edc372,
title = "Accelerometry as a measure of walking behavior in multiple sclerosis",
abstract = "Objective: Accelerometry has been identified as a possible ecologically valid and objective approach for measuring community ambulation in multiple sclerosis (MS). This study provides a validation of accelerometer output based on associations with Expanded Disability Status Scale (EDSS), Patient Determined Disease Steps (PDDS) Scale, and Multiple Sclerosis Walking Scale-12 (MSWS-12) scores, timed 25-foot walk (T25FW) and 6-min walk (6MW) performance, oxygen cost (O 2 cost) of walking, and spatial and temporal parameters of gait. Materials and Methods: 256 persons with MS completed the PDDS and MSWS-12, underwent an examination for the generation of an EDSS score, undertook two T25FW tests and a 6MW while wearing a portable metabolic unit for measuring the O 2 cost of walking, completed two trials of comfortable walking on a GAITRite electronic walkway for measuring spatial and temporal parameters of gait, and then wore an Actigraph accelerometer during the waking hours of a 7-day period. Results: The accelerometer output was significantly correlated with EDSS (ρ = -0.522), PDDS (ρ = -0.551), and MSWS-12 (ρ = -0.617) scores, T25FW (ρ = -0.595) and 6MW (ρ = 0.630) performance, and O 2 cost of walking (ρ = -0.457). Regarding gait parameters, the accelerometer output was significantly correlated with velocity (ρ = 0.420), cadence (ρ = 0.349), step time (ρ = -0.353), step length (ρ = 0.395), double support (ρ = -0.424), and single support (ρ = 0.400). Conclusion: We provide comprehensive evidence from a large sample of persons with MS that further supports accelerometry as a measure of walking behavior.",
keywords = "Ambulation, Mobility, Multiple sclerosis, Neurology, Walking",
author = "Motl, {Robert W} and Lara Pilutti and Sandroff, {B. M.} and D. Dlugonski and Sosnoff, {Jacob J} and Pula, {J. H.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1111/ane.12036",
language = "English (US)",
volume = "127",
pages = "384--390",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Accelerometry as a measure of walking behavior in multiple sclerosis

AU - Motl, Robert W

AU - Pilutti, Lara

AU - Sandroff, B. M.

AU - Dlugonski, D.

AU - Sosnoff, Jacob J

AU - Pula, J. H.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Objective: Accelerometry has been identified as a possible ecologically valid and objective approach for measuring community ambulation in multiple sclerosis (MS). This study provides a validation of accelerometer output based on associations with Expanded Disability Status Scale (EDSS), Patient Determined Disease Steps (PDDS) Scale, and Multiple Sclerosis Walking Scale-12 (MSWS-12) scores, timed 25-foot walk (T25FW) and 6-min walk (6MW) performance, oxygen cost (O 2 cost) of walking, and spatial and temporal parameters of gait. Materials and Methods: 256 persons with MS completed the PDDS and MSWS-12, underwent an examination for the generation of an EDSS score, undertook two T25FW tests and a 6MW while wearing a portable metabolic unit for measuring the O 2 cost of walking, completed two trials of comfortable walking on a GAITRite electronic walkway for measuring spatial and temporal parameters of gait, and then wore an Actigraph accelerometer during the waking hours of a 7-day period. Results: The accelerometer output was significantly correlated with EDSS (ρ = -0.522), PDDS (ρ = -0.551), and MSWS-12 (ρ = -0.617) scores, T25FW (ρ = -0.595) and 6MW (ρ = 0.630) performance, and O 2 cost of walking (ρ = -0.457). Regarding gait parameters, the accelerometer output was significantly correlated with velocity (ρ = 0.420), cadence (ρ = 0.349), step time (ρ = -0.353), step length (ρ = 0.395), double support (ρ = -0.424), and single support (ρ = 0.400). Conclusion: We provide comprehensive evidence from a large sample of persons with MS that further supports accelerometry as a measure of walking behavior.

AB - Objective: Accelerometry has been identified as a possible ecologically valid and objective approach for measuring community ambulation in multiple sclerosis (MS). This study provides a validation of accelerometer output based on associations with Expanded Disability Status Scale (EDSS), Patient Determined Disease Steps (PDDS) Scale, and Multiple Sclerosis Walking Scale-12 (MSWS-12) scores, timed 25-foot walk (T25FW) and 6-min walk (6MW) performance, oxygen cost (O 2 cost) of walking, and spatial and temporal parameters of gait. Materials and Methods: 256 persons with MS completed the PDDS and MSWS-12, underwent an examination for the generation of an EDSS score, undertook two T25FW tests and a 6MW while wearing a portable metabolic unit for measuring the O 2 cost of walking, completed two trials of comfortable walking on a GAITRite electronic walkway for measuring spatial and temporal parameters of gait, and then wore an Actigraph accelerometer during the waking hours of a 7-day period. Results: The accelerometer output was significantly correlated with EDSS (ρ = -0.522), PDDS (ρ = -0.551), and MSWS-12 (ρ = -0.617) scores, T25FW (ρ = -0.595) and 6MW (ρ = 0.630) performance, and O 2 cost of walking (ρ = -0.457). Regarding gait parameters, the accelerometer output was significantly correlated with velocity (ρ = 0.420), cadence (ρ = 0.349), step time (ρ = -0.353), step length (ρ = 0.395), double support (ρ = -0.424), and single support (ρ = 0.400). Conclusion: We provide comprehensive evidence from a large sample of persons with MS that further supports accelerometry as a measure of walking behavior.

KW - Ambulation

KW - Mobility

KW - Multiple sclerosis

KW - Neurology

KW - Walking

UR - http://www.scopus.com/inward/record.url?scp=84877921839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877921839&partnerID=8YFLogxK

U2 - 10.1111/ane.12036

DO - 10.1111/ane.12036

M3 - Article

C2 - 23240822

AN - SCOPUS:84877921839

VL - 127

SP - 384

EP - 390

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 6

ER -